At UMass Memorial Cancer Center of Excellence in Worcester, MA, we work in partnership with the
University of Massachusetts Medical School to research new treatments for cancer. UMass Memorial is at the forefront of some of the nation’s most promising research and treatment programs. Through our Cancer Center Clinical Research Office (CRO), we perform
breakthrough research and
clinical trials
to improve treatment and your quality of life.
Liver Cancer Trials Underway
ECOG E1208
A Phase III Randomized, Double-Blind Trial of Chemoembolization with or without Sorafenib in Unresectable Hepatocellular Carcinoma (HCC) in Patients with and without Vascular Invasion
INVESTIGATOR: Bradley Switzer, MD
SPONSOR: National Cancer Institute (NCI)
ECOG E1208 at clinicaltrials.gov
ImClone REACH
A multicenter, randomized, double-blind, phase 3 study of Ramucirumab (IMC-1121B) drug product and best supportive care (BSC) versus placebo and BSC as second-line treatment in patients with hepatocellular carcinoma following first-line therapy with sorafenib
INVESTIGATOR: Venu Bathini, MD
SPONSOR: ImClone LLC (a wholly-owned subsidiary of Eli Lilly and Company)
ImClone REACH at clinicaltrials.gov
Learn more about research and other clinical trials underway at the UMass Memorial Cancer Center of Excellence.
|
Liver Cancer Studies Recruiting:
To learn more about clinical trials and cancer research,
call 508-856-3216 or email cancer.research@umassmed.edu
|